首页>
外国专利>
RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE
RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE
展开▼
机译:RAC1抑制剂治疗轻度肾小球疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods of treating Alport syndrome in a subject by the administration of an agent that blocks the activation of RAC1/CDC42 members of the rho family of small GTPases. Such agents include, but are not limited to, the endothelin receptor antagonists such as bosentan and letairis and neutralizing antibodies to endothelin-1. Such administration prevents invasion of the glomerular capillary tufts by mesangial lamellipodial/filopodial processes, blocks mesangial process invasion abrogates the deposition of laminin 211 in the GBM, and prevents the activation of maladaptive expression of proteins known to contribute to glomerular disease progression.
展开▼